Cargando…

Pre‐operative risk factors for driveline infection in left ventricular‐assist device patients

AIMS: Implantation of left ventricular‐assist devices (LVAD) to treat end‐stage heart failure is of increasing relevance due to donor shortage. Infections of the driveline are common adverse events. LVAD infections can lead to high urgency listings for transplantation. However, transplantation in pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Köhler, Ann‐Kristin, Körperich, Hermann, Morshuis, Michiel, Freytag, Claudia Christine, Gummert, Jan, Burchert, Wolfgang, Preuss, Rainer, Körfer, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773640/ https://www.ncbi.nlm.nih.gov/pubmed/35997005 http://dx.doi.org/10.1002/ehf2.14112

Ejemplares similares

Left ventricular assist device driveline infections in three contemporary devices
por: Schlöglhofer, Thomas, et al.
Publicado: (2020)

2765. Dalbavancin for challenging left ventricular assist device driveline infections
por: Doligalski, Christina, et al.
Publicado: (2023)

Bowel obstruction due to retained intraperitoneal left ventricular assist device (LVAD) driveline
por: Miklin, Daniel, et al.
Publicado: (2018)

Driveline Features as Risk Factor for Infection in Left Ventricular Assist Devices: Meta-Analysis and Experimental Tests
por: Kranzl, Melanie, et al.
Publicado: (2021)

Safety, Mortality, and Hemodynamic Impact of Patients with MitraClip Undergoing Left Ventricular Assist Device Implantation
por: Fox, Henrik, et al.
Publicado: (2021)

Multi-parametric analyses to investigate dependencies of normal left atrial strain by cardiovascular magnetic resonance feature tracking
por: Eckstein, Jan, et al.
Publicado: (2022)

Calciotropic and Phosphaturic Hormones in End-Stage Heart Failure Patients Supported by a Left-Ventricular Assist Device
por: Zittermann, Armin, et al.
Publicado: (2016)

Renal Function in Patients with or without a Left Ventricular Assist Device Implant During Listing for a Heart Transplant
por: Zittermann, Armin, et al.
Publicado: (2020)

Interplay between driveline infection, vessel wall inflammation, cerebrovascular events and mortality in patients with left ventricular assist device
por: Hupe, Juliane, et al.
Publicado: (2023)

1540. Left Ventricular Assist Device Driveline Infections: Relapsed Infections and Minimum Inhibitory Concentration Changes
por: Lines, Tara, et al.
Publicado: (2018)

Driveline exit-site care protocols in patients with left ventricular assist devices: a systematic review
por: Koken, Zeliha Ozdemir, et al.
Publicado: (2021)

Retained left ventricular assist device driveline in a heart transplant recipient: A case report
por: Kim, Juka S., et al.
Publicado: (2022)

Eradication of Ventricular Assist Device Driveline Infection in Paediatric Patients with Taurolidine
por: Weichsel, Johannes, et al.
Publicado: (2022)

Bacteriophage-Enriched Galenic for Intrapericardial Ventricular Assist Device Infection
por: Rojas, Sebastian V., et al.
Publicado: (2022)

No Association between Clinical Periodontal Conditions and Microbiological Findings on Driveline of Patients with Left-Ventricular Assist Devices (LVAD)
por: Schmalz, Gerhard, et al.
Publicado: (2021)

Complications of left ventricular assist devices causing high urgency status on waiting list: impact on outcome after heart transplantation
por: Immohr, Moritz Benjamin, et al.
Publicado: (2021)

Anti-infective characteristics of a new Carbothane ventricular assist device driveline
por: Qu, Yue, et al.
Publicado: (2023)

Left-Ventricular Reference Myocardial Strain Assessed by Cardiovascular Magnetic Resonance Feature Tracking and fSENC—Impact of Temporal Resolution and Cardiac Muscle Mass
por: Weise Valdés, Elena, et al.
Publicado: (2021)

Driveline Infection in Ventricular Assist Devices and Its Implication in the Present Era of Destination Therapy
por: Hernandez, Gabriel A, et al.
Publicado: (2017)

Evolution of thrombolytic therapy in patients with HeartWare ventricular assist device thrombosis: a single-institutional experience
por: Fox, Henrik, et al.
Publicado: (2022)

Lessons learned from catheter ablation of ventricular arrhythmias in patients with a fully magnetically levitated left ventricular assist device
por: Bergau, Leonard, et al.
Publicado: (2021)

Pharmacokinetic Assessment of Continuous Infusion Ceftolozane/Tazobactam for Drug-Resistant Pseudomonas aeruginosa Left Ventricular Assist Device Driveline Infection
por: Foster, Rachel, et al.
Publicado: (2017)

Successful Bacteriophage-Antibiotic Combination Therapy against Multidrug-Resistant Pseudomonas aeruginosa Left Ventricular Assist Device Driveline Infection
por: Racenis, Karlis, et al.
Publicado: (2023)

Facilitating heart transplantability in an end-stage heart failure patient with brain abscess and infected left ventricle assist device—A unique case report
por: Ibrahim, Mohamad, et al.
Publicado: (2020)

Repair of left ventricular driveline tear in a SynCardia-total artificial heart patient
por: Spiliopoulos, Sotirios, et al.
Publicado: (2014)

Decreasing driveline infections in patients supported on ventricular assist devices: a care pathway approach
por: Seretny, Julia, et al.
Publicado: (2022)

A Machine Learning Challenge: Detection of Cardiac Amyloidosis Based on Bi-Atrial and Right Ventricular Strain and Cardiac Function
por: Eckstein, Jan, et al.
Publicado: (2022)

CMR-based right ventricular strain analysis in cardiac amyloidosis and its potential as a supportive diagnostic feature
por: Eckstein, Jan, et al.
Publicado: (2022)

Driveline Sepsis Presenting As Gout
por: Toms, Brittney
Publicado: (2020)

SdrF, a Staphylococcus epidermidis Surface Protein, Contributes to the Initiation of Ventricular Assist Device Driveline–Related Infections
por: Arrecubieta, Carlos, et al.
Publicado: (2009)

In vitro Evaluation of Medihoney Antibacterial Wound Gel as an Anti-biofilm Agent Against Ventricular Assist Device Driveline Infections
por: Qu, Yue, et al.
Publicado: (2020)

Left ventricular assist device implants in patients on extracorporeal membrane oxygenation: do we need cardiopulmonary bypass?
por: Pappalardo, Federico, et al.
Publicado: (2021)

Identification of characteristics, risk factors, and predictors of recurrent LVAD thrombosis: conditions in HeartWare devices
por: Gyoten, Takayuki, et al.
Publicado: (2020)

Local Treatment of Driveline Infection with Bacteriophages
por: Püschel, Anja, et al.
Publicado: (2022)

Left Ventricular Unloading in Patients on Venoarterial Extracorporeal Membrane Oxygenation Therapy in Cardiogenic Shock: Prophylactic Versus Bail-Out Strategy
por: Radakovic, Darko, et al.
Publicado: (2023)

Left ventricular mass estimation by real-time 3D echocardiography favourably competes with CMR in congenital left ventricular disease
por: Michel, Miriam, et al.
Publicado: (2019)

The Role of Daily Implant-Based Multiparametric Telemonitoring in Patients with a Ventricular Assist Device
por: Guckel, Denise, et al.
Publicado: (2022)

Noninvasive evaluation of the hemodynamic status in patients after heart transplantation or left ventricular assist device implantation
por: Roth, Sebastian, et al.
Publicado: (2022)

Successful repeated thrombolysis in a patient with HeartWare thrombosis – the importance of Doppler flow pattern
por: Paluszkiewicz, Lech, et al.
Publicado: (2014)

Magnetic-Resonance-Imaging-Based Left Atrial Strain and Left Atrial Strain Rate as Diagnostic Parameters in Cardiac Amyloidosis
por: Sciacca, Vanessa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iiebgkbv2b9v662ht40itjmonp